Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104


MiR-379-5p improved locomotor function recovery after spinal cord injury in rats by reducing endothelin 1 and inhibiting astrocytes expression.

A JC, Li ZY, Long QF, Wang DY, Zhao HS, Jia SL, Zhang WH.

Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9738-9745. doi: 10.26355/eurrev_201911_19536.


Inhibition of miR-214-5p attenuates inflammatory chemotaxis and nerve regeneration obstruction after spinal cord injury in rats.

Wang P, Li ZW, Zhu Z, Zhang ZY, Liu J.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2332-2339. doi: 10.26355/eurrev_201903_17376.


MiR-223-5p inhibitor suppresses microglia inflammation and promotes Nrg-1 in rats of spinal cord injury.

Guan YZ, Sun C, Wang HL, Xia XL, Lu FZ, Song J, Ma XS, Jiang JY.

Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9746-9753. doi: 10.26355/eurrev_201911_19537.


MiR-543-5p inhibits inflammation and promotes nerve regeneration through inactivation of the NF-κB in rats after spinal cord injury.

Zhao CL, Cui HA, Zhang XR.

Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):39-46. doi: 10.26355/eurrev_201908_18626.


MiR-543-3p promotes locomotor function recovery after spinal cord injury by inhibiting the expression of tumor necrosis factor superfamily member 15 in rats.

Li XZ, Lv CL, Shi JG, Zhang CX.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2701-2709. doi: 10.26355/eurrev_201904_17540.


MiR-219-5p promotes spinal cord injury recovery by inhibiting NEUROD2-regulated inflammation and oxidative stress.

Zhu Y, Xu Q, Sha WP, Zhao KP, Wang LM.

Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):37-43. doi: 10.26355/eurrev_201901_16745.


Protective Effects of MiR-129-5p on Acute Spinal Cord Injury Rats.

Yang R, Cai X, Li J, Liu F, Sun T.

Med Sci Monit. 2019 Nov 4;25:8281-8288. doi: 10.12659/MSM.916731.


MiR-21 inhibitor improves locomotor function recovery by inhibiting IL-6R/JAK-STAT pathway-mediated inflammation after spinal cord injury in model of rat.

Ning SL, Zhu H, Shao J, Liu YC, Lan J, Miao J.

Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):433-440. doi: 10.26355/eurrev_201901_16852.


MiR-92b-5p inhibitor suppresses IL-18 mediated inflammatory amplification after spinal cord injury via IL-18BP up-regulation.

Lin XL, Zhu J, Wang LM, Yan F, Sha WP, Yang HL.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):1891-1898. doi: 10.26355/eurrev_201903_17226.


Inhibition of miR-17-5p promotes mesenchymal stem cells to repair spinal cord injury.

Yue XH, Guo L, Wang ZY, Jia TH.

Eur Rev Med Pharmacol Sci. 2019 May;23(9):3899-3907. doi: 10.26355/eurrev_201905_17819.


MiR-137-5p alleviates inflammation by upregulating IL-10R1 expression in rats with spinal cord injury.

Lv ZC, Cao XY, Guo YX, Zhang XD, Ding J, Geng J, Feng K, Niu H.

Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4551-4557. doi: 10.26355/eurrev_201906_18030.


Molecular Mechanism of MiR-136-5p Targeting NF-κB/A20 in the IL-17-Mediated Inflammatory Response after Spinal Cord Injury.

He J, Zhao J, Peng X, Shi X, Zong S, Zeng G.

Cell Physiol Biochem. 2017;44(3):1224-1241. doi: 10.1159/000485452. Epub 2017 Nov 28.


Upregulation of miR-199a-5p Protects Spinal Cord Against Ischemia/Reperfusion-Induced Injury via Downregulation of ECE1 in Rat.

Bao N, Fang B, Lv H, Jiang Y, Chen F, Wang Z, Ma H.

Cell Mol Neurobiol. 2018 Aug;38(6):1293-1303. doi: 10.1007/s10571-018-0597-2. Epub 2018 Jun 13.


Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury.

Yamaya S, Ozawa H, Kanno H, Kishimoto KN, Sekiguchi A, Tateda S, Yahata K, Ito K, Shimokawa H, Itoi E.

J Neurosurg. 2014 Dec;121(6):1514-25. doi: 10.3171/2014.8.JNS132562. Epub 2014 Oct 3.


Zhenbao pill protects against acute spinal cord injury via miR-146a-5p regulating the expression of GPR17.

He Y, Lv B, Huan Y, Liu B, Li Y, Jia L, Qu C, Wang D, Yu H, Yuan H.

Biosci Rep. 2018 Jan 19;38(1). pii: BSR20171132. doi: 10.1042/BSR20171132. Print 2018 Feb 28.


PHBV/PLA/Col-Based Nanofibrous Scaffolds Promote Recovery of Locomotor Function by Decreasing Reactive Astrogliosis in a Hemisection Spinal Cord Injury Rat Model.

Zhao T, Jing Y, Zhou X, Wang J, Huang X, Gao L, Zhu Y, Wang L, Gou Z, Liang C, Xu K, Li F, Chen Q.

J Biomed Nanotechnol. 2018 Nov 1;14(11):1921-1933. doi: 10.1166/jbn.2018.2622.


MiR-325-3p promotes locomotor function recovery in rats with spinal cord injury via inhibiting the expression of neutrophil elastase.

Sun JD, Zeng YH, Zhang Y, Yang XX, Zeng WJ, Zhao LS, Liang CG.

Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10631-10637. doi: 10.26355/eurrev_201912_19760.


Mulberrin (Mul) reduces spinal cord injury (SCI)-induced apoptosis, inflammation and oxidative stress in rats via miroRNA-337 by targeting Nrf-2.

Xia P, Gao X, Duan L, Zhang W, Sun YF.

Biomed Pharmacother. 2018 Nov;107:1480-1487. doi: 10.1016/j.biopha.2018.07.082. Epub 2018 Sep 4.


Post-spinal cord injury astrocyte-mediated functional recovery in rats after intraspinal injection of the recombinant adenoviral vectors Ad5-VEGF and Ad5-ANG.

Povysheva T, Shmarov M, Logunov D, Naroditsky B, Shulman I, Ogurcov S, Kolesnikov P, Islamov R, Chelyshev Y.

J Neurosurg Spine. 2017 Jul;27(1):105-115. doi: 10.3171/2016.9.SPINE15959. Epub 2017 Apr 28.


Supplemental Content

Support Center